Common GI Side Effects Nausea, vomiting, diarrhea, constipation, abdominal pain, distension, dyspepsia, flatulence, and belching hit up to 50% of users during dose escalation
In the STEP 1 trial: Participants who took the medication lost an average of 14.9% of their body weight over 68 weeks By comparison, those who received a placebo lost only 2.4% Nearly 86% of GLP-1 users lost at least 5% of their body weight, an important clinical marker Additional real-world data backs this up
So, what does microdosing GLP-1s look like
About the Author Aaron serves as Editor at LovelySkin
They discovered that while semaglutide didnt make the cells more responsive to insulin, it did boost the number and activity of mitochondria, which are the powerhouses of the cells
Caffeine and Alcohol Drinking alcohol, soda, or coffee within a few hours of bedtime can disrupt sleep